The full scope of treatment includes: medication, provider access, prescription updates, the app, regular check-ins, and shipping
Key results 20% reduction in major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) 3 19% reduction in all-cause mortality 3 Average weight loss of approximately 9.4% 3 For people already on statins who also have obesity, the SELECT data shows that adding Wegovy reduced their rate of heart attacks, strokes, and cardiovascular death by one-fifth, even though they were already receiving optimised statin therapy
Congenital urinary tract obstruction: the long view
Most consumers prefer liposomal formulations as they are engineered to deliver nutrients better than traditional oral supplements
Lilly's Foundayo pill, with active ingredient orforglipron, will begin shipping on Monday
Adjusting the dose helps reduce unwanted side effects and improves safety for each patient